News
Jubilant Pharmova receives ratings for proposed NCDs of Rs 1400 cr
21-Oct-2026 | 18:59
Jubilant Pharmova announced that India Ratings and Research has assigned the credit rating IND AA+; Stable to the company's proposed non-convertible debentures of Rs 1400 crore.